An observational study in Coronary Stenosis, Coronary Occlusion and Coronary Disease, sponsored by Seung-Jung Park. Recruiting at 6 sites in South Korea. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-06-24.
Sponsored by Seung-Jung Park · Observational
This study evaluates effectiveness and safety of DESyne X2 in Routine Clinical Practice.
326 studies on the registry are indexed under Coronary Stenosis; 57 are open to participants now.
This study's planned enrollment of 1,000 is above the median of 200 across 125 observational studies indexed under Coronary Stenosis.
Browse Coronary Stenosis studies →Seung-Jung Park is the lead sponsor of 82 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients with DeSyne X2 stent
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: DESyne X2
Novolimus-eluting stent
Composite event rate
Death, non-fatal myocardial infarction, Target Vessel Revascularization
Time frame: 1year
All death
Time frame: 5years
Cardiac death
Time frame: 5years
Myocardial infarction
Time frame: 5years
Composite event of death or myocardial infarction
Time frame: 5years
Composite event of cardiac death or myocardial infarction
Time frame: 5years
Target Vessel revascularization
Time frame: 5years
Target Lesion revascularization
Time frame: 5years
Stent thrombosis
stent thrombosis as classified by an Academic Research Consortium
Time frame: 5years
Stroke
Time frame: 5years
Procedural success
defined as achievement of a final diameter stenosis of \<30% by visual estimation, without the occurrence of death, Q-wave MI, or urgent revascularization during the index hospitalization.
Time frame: 3days
Not enrolling at this site.
Not enrolling at this site.
Not enrolling at this site.
Not enrolling at this site.
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seung-Jung Park